Alnylam Pharmaceuticals
ALNY
#570
Rank
ยฃ28.78 B
Marketcap
ยฃ223.15
Share price
1.16%
Change (1 day)
57.28%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: ยฃ28.78 Billion

As of January 2025 Alnylam Pharmaceuticals has a market cap of ยฃ28.78 Billion. This makes Alnylam Pharmaceuticals the world's 570th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ28.78 B17.68%
2024ยฃ24.45 B29.72%
2023ยฃ18.85 B-21.98%
2022ยฃ24.16 B60.84%
2021ยฃ15.02 B35.63%
2020ยฃ11.07 B12.43%
2019ยฃ9.85 B69.55%
2018ยฃ5.81 B-37.66%
2017ยฃ9.32 B258.04%
2016ยฃ2.60 B-51.83%
2015ยฃ5.40 B12.38%
2014ยฃ4.80 B93.58%
2013ยฃ2.48 B319.24%
2012ยฃ0.59 B164.54%
2011ยฃ0.22 B-17.16%
2010ยฃ0.27 B-40.63%
2009ยฃ0.45 B-34.81%
2008ยฃ0.69 B17.08%
2007ยฃ0.59 B47.44%
2006ยฃ0.40 B170.95%
2005ยฃ0.14 B99.11%
2004ยฃ75.03 M

End of Day market cap according to different sources

On Jan 30th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

ยฃ28.78 Billion
by Yahoo Finance info icon info icon
ยฃ28.78 Billion
by CompaniesMarketCap info icon info icon
ยฃ28.78 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ2.03 B-92.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ60.43 B 109.98%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.80 B-69.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.81 B-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ52.73 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ169.26 B 488.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ111.34 B 286.85%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ16.42 B-42.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel